GBT

Global Blood Therapeutics, Inc.
GBT

Overview Fund Activity
Delisted

GBT was delisted on the 4th of October, 2022.

Back to rankings

203 hedge funds and large institutions have $2.4B invested in Global Blood Therapeutics, Inc. in 2022 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 78 increasing their positions, 62 reducing their positions, and 30 closing their positions.

Holders
203
Holders Change
-2
Holders Change %
-0.98%
% of All Funds
3.21%
Holding in Top 10
10
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+42.86%
% of All Funds
0.16%
New
31
Increased
78
Reduced
62
Closed
30
Calls
$13.9M
Puts
$14M
Net Calls
-$21K
Net Calls Change
-$4.27M

Top Buyers

1
O
1
OrbiMed
New York
$54.6M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$31.9M
3
Goldman Sachs
3
Goldman Sachs
New York
$63.5M
4
LGM
4
Logos Global Management
California
$43.3M
5
PA
5
Perceptive Advisors
New York
$135M

Top Sellers

1
Capital World Investors
1
Capital World Investors
California
$0
2
APM
2
Avidity Partners Management
Texas
$0
3
Jacobs Levy Equity Management
3
Jacobs Levy Equity Management
New Jersey
$0
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$142M
5
Voloridge Investment Management
5
Voloridge Investment Management
Florida
$2.05M
Name Holding Trade Value Shares
Change 		Shares
Change %
DFCM
226
Dark Forest Capital Management
Puerto Rico
– -$5K -168 Closed
SWM
227
Spire Wealth Management
Virginia
– -$4K -135 Closed
EBA
228
Eagle Bay Advisors
New York
– -$2K -80 Closed
6 7 8 9
10